Due to the current situation with the coronavirus, the International Clinical Trials Day 2020 in Berlin have been cancelled.
TRANSVAC2, an European Vaccine Research and Development Infrastructure, supports innovation and accelerates vaccine development by offering high-quality technical services across the R&D pipeline to academic and non-academic research groups, including SMEs.
The world is confronted with the COVID-19 crisis, and all working in healthcare systems taking care of patients have the highest priority. Behind the scenes all forces are joined to support those working to find a cure and a vaccine for COVID-19.
An article related to PedCRIN's work has recently been published in Clinical and Translational Science (CTS) entitled 'Involve Children and Parents in Clinical Studies'.
The ERIC Forum met for its annual meeting from 5-6 February 2020 in Brussels. Representatives from all ERICs (European Research Infrastructure Consortia), including ECRIN, attended.
EU Commission Call: Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic
The European Commission has issued an emergency request for expressions of interest for research projects that will advance understanding of the coronavirus epidemic and contribute to a more efficient public health response. Application deadline: 12 February 2020.
The ERIC Forum, which brings together 21 leading European Research Infrastructures, has a new leadership. The aim of the ERIC Forum is to advance operations of ERICs and to strategically contribute to the development of ERIC-related policies.
As part of its Data Management Centre Certification programme, ECRIN conducted an initial audit of the Medical Research Collaboration Center (MRCC) at Seoul National University Hospital in Seoul, South Korea, from January 13th to 17th, 2020.
New Paper: Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
The ECRIN-supported CORBEL project has published a new paper entitled 'Selecting Core Outcomes for
Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes'.
The innovative 'Rare Diseases Research (RDR) Challenges' call will be implemented to facilitate and fund collaboration between industry, academia, SMEs, and patient organisations to solve specific research challenges in rare diseases.
The third Advisory Board meeting for the PedCRIN project will be held at ECRIN's office in Paris on the 29th of January 2020.
The European Joint Programme on Rare Diseases (EJP-RD) - an ECRIN-supported, patient-centred initiative to foster rare disease research - has opened a Networking Support Scheme (NSS). Health care professionals, researchers
EULAC PerMed, a European project funded by the Horizon 2020 Research and Innovation Programme, organised the 'Great Week of Personalised Medicine' in Montevideo, Uruguay, from 9 to 13 December 2019.
Press Release: The EU-PEARL project aims to shape future drug development through a systematic approach that enables patient focused, cross company collaborative platform trials
Press Release – 18/12/19
Subscription Now Possible to TBMed (A testing bed for the development of high-risk medical devices) Newsletter
It is now possible to subscribe to the TBMED (A testing bed for the development of high-risk medical devices) project newsletter. To do so, please click here.
Five years after its establishment, ECRIN-ERIC underwent in 2019 an external and independent scientific evaluation carried-out by ERIEC, an international consortium of research evaluation agencies.
ICPerMed's third 'Best Practice in Personalised Medicine' Recognition 2020 will honour, encourage, promote and disseminate outstanding best practice examples in personalised medicine.
The EU-PEARL (EU Patient-cEntric clinicAl tRial pLatform) project is holding its kick-off meeting from 21 to 22 November 2019 in Brussels.
The Preliminary Announcement of the European Joint Programme on Rare Diseases (EJP RD) Joint Transnational Call (JTC) 2020 is online.
The topic is: PRE-CLINICAL RESEARCH TO DEVELOP EFFECTIVE THERAPIES FOR RARE DISEASES.
The Clinical Trials Methodology Demonstration Projects Call of the European Joint Programme on Rare Diseases (EJP RD) project is now open.
Please note that this call is open only for teams from institutions that are beneficiaries of the EJP RD project.